Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.48 HKD
−107.72 M HKD
45.25 M HKD
89.81 M
About CRYOFOCUS MEDTECH SHANGHAI CO LTD
Sector
Industry
CEO
Jun Zhu
Website
Headquarters
Shanghai
Founded
2013
ISIN
CNE100005MV5
FIGI
BBG01C1KH3Y4
Cryofocus Medtech (Shanghai) Co. Ltd. medical device company, which manufactures cryoablation devices. Its products are bladder cyoablation system and the endoscopic clip for anastomosis. The company was founded on March 15, 2013 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6922 is 6.99 HKD — it hasn't changed in the past 24 hours. Watch CRYOFOCUS MEDTECH SHANGHAI CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CRYOFOCUS MEDTECH SHANGHAI CO LTD stocks are traded under the ticker 6922.
6922 stock has risen by 0.29% compared to the previous week, the month change is a 1.45% rise, over the last year CRYOFOCUS MEDTECH SHANGHAI CO LTD has showed a −62.82% decrease.
6922 reached its all-time high on Oct 3, 2023 with the price of 19.50 HKD, and its all-time low was 5.00 HKD and was reached on May 20, 2024. View more price dynamics on 6922 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6922 stock is 0.14% volatile and has beta coefficient of 0.71. Track CRYOFOCUS MEDTECH SHANGHAI CO LTD stock price on the chart and check out the list of the most volatile stocks — is CRYOFOCUS MEDTECH SHANGHAI CO LTD there?
Yes, you can track CRYOFOCUS MEDTECH SHANGHAI CO LTD financials in yearly and quarterly reports right on TradingView.
CRYOFOCUS MEDTECH SHANGHAI CO LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
6922 net income for the last half-year is −56.53 M HKD, while the previous report showed −58.43 M HKD of net income which accounts for 3.24% change. Track more CRYOFOCUS MEDTECH SHANGHAI CO LTD financial stats to get the full picture.
No, 6922 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 392.00 employees. See our rating of the largest employees — is CRYOFOCUS MEDTECH SHANGHAI CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRYOFOCUS MEDTECH SHANGHAI CO LTD EBITDA is −122.77 M HKD, and current EBITDA margin is −269.46%. See more stats in CRYOFOCUS MEDTECH SHANGHAI CO LTD financial statements.
Like other stocks, 6922 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRYOFOCUS MEDTECH SHANGHAI CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRYOFOCUS MEDTECH SHANGHAI CO LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRYOFOCUS MEDTECH SHANGHAI CO LTD stock shows the sell signal. See more of CRYOFOCUS MEDTECH SHANGHAI CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.